Compare Inovio Pharmaceuticals Inc (INO) vs Waste Management, Inc. (WM) Price & Performance

INO trades at $1.07, down 4.46% today, reflecting persistent bearish technical signals. The company shows minimal revenue of $65.34K (2025) with a net loss of $84.95M, resulting in a negative net margin of 130,000%. Despite beating recent EPS estimates, cash flow remains negative. Key near-term catalyst is the FDA's PDUFA decision on INO-3107 by October 30, 2026.

Outlook hinges on regulatory success for INO-3107; approval could drive significant upside, but failure poses substantial risk. High cash burn and lack of profitability underscore speculative nature. Analyst consensus is cautiously optimistic with 53% buy ratings, yet financial health remains precarious without near-term revenue growth.

WM trades at $239.26, showing minimal daily movement with a slight 0.02% decline. The stock maintains a bullish technical outlook with strong moving average signals and trades near its pivot point of $241. Fundamentally, the company demonstrates solid revenue growth from $19.7B in 2022 to $25.2B in 2025, though recent quarters show mixed earnings performance with two misses and one beat against expectations.

WM presents a stable investment case with consistent dividend payments and strong analyst support (57% buy ratings), but faces challenges from elevated debt levels and valuation multiples. The consensus price target of $263.57 suggests 10% upside potential, though investors should monitor execution on earnings guidance and debt management in the coming quarters.